Key points from article :
Researchers at the University of Miami have opened a state-of-the-art 3D bioprinting facility that aims to bring personalised medicine and regenerative therapies closer to routine clinical care. Unlike conventional 3D printing, which uses materials such as plastic or metal, bioprinting works with living cells, proteins and biomaterials to create tissues, implants and drug delivery systems designed for individual patients.
The new facility is already being used to develop a wide range of technologies, including artificial tissues, patient-specific implants, bone regeneration scaffolds, microneedles for drug delivery and microfluidic devices for rapid diagnostic testing. By printing at physiological temperatures, researchers can preserve living cells and delicate biological molecules that would be destroyed by the high temperatures used in many traditional 3D printing methods.
One of the most advanced projects focuses on 3D-printed scaffolds that encourage the body to regrow bone lost through injury, disease or surgery. The technology has already shown promising results in animal studies, and researchers are preparing for future clinical trials. Scientists are also exploring ways to bioprint skin, cartilage, nerve tissue and even artificial organs, although significant challenges remain before these can be widely used in patients.
While many of these technologies are still in development, the new facility represents an important step towards making bioprinting a practical medical tool. By bringing engineers, clinicians and researchers together under one roof, the centre hopes to accelerate the development of personalised treatments that could transform surgery, regenerative medicine and drug delivery in the years ahead.
